METex14 skipping mutations result in the deletion from the transcript of a domain implicated in the internalization and degradation of the receptor complex, leading to sustained activity of the MET-HGF signaling pathway, aberrant cell proliferation, and NSCLC tumor growth [9, 10]. The gene discussed is MET; the disease is non-small cell lung carcinoma.